From: “A rising tide lifts all boats”: establishing a multidisciplinary genomic tumor board for breast cancer patients with advanced disease
Tumor Type
Number
Percent
Triple negative
25
63
Hormone receptor positive/HER2 negative
12
30
HER2 overexpressed
3
7